Literature DB >> 2889403

Continuous infusion of vecuronium: the effect of anesthetic agents.

J E Cannon1, M R Fahey, K P Castagnoli, T Furuta, P C Canfell, M Sharma, R D Miller.   

Abstract

The authors studied the effects of enflurane, isoflurane, and fentanyl, each in combination with 60% nitrous oxide, on the vecuronium infusion rate necessary to maintain constant 90% depression of control muscle twitch tension. Thirty healthy surgical patients were given an initial 0.1 mg/kg bolus of vecuronium, followed by an infusion of vecuronium at an initial rate of 1.0 microgram . kg-1 . min-1. After 1 h of steady-state 90% twitch depression, plasma vecuronium concentrations (Css90) were measured by capillary column gas chromatography. Total plasma clearance of vecuronium was estimated using Css90 values. Vecuronium infusion rates (mean +/- SD) were similar for patients given enflurane (0.28 +/- 0.13 microgram . kg-1 . min-1) and isoflurane (0.30 +/- 0.13 microgram . kg-1 . min-1), but significantly higher in patients given fentanyl (0.92 +/- 0.37 microgram . kg-1 . min-1). Values for Css90 in the patients receiving enflurane and isoflurane were similar (71 +/- 34 and 72 +/- 44 ng/ml, respectively), but significantly higher in those receiving fentanyl (165 +/- 48 ng/ml). Total plasma clearance was similar during enflurane, isoflurane, and fentanyl anesthesia (4.4 +/- 2.6, 4.6 +/- 1.2, and 5.6 +/- 1.9 ml X kg-1 min-1, respectively). The authors conclude that patients receiving isoflurane and enflurane require markedly lower vecuronium infusion rates to achieve 90% neuromuscular blockade than those receiving fentanyl. The enhancement of neuromuscular blockade by isoflurane and enflurane represents a change in the pharmacodynamics of vecuronium-induced neuromuscular blockade, rather than a change in pharmacokinetics.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889403     DOI: 10.1097/00000542-198710000-00010

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Intraoperative electrophysiologic monitoring of ocular motor nerves under conditions of partial neuromuscular blockade during skull base surgery.

Authors:  M Kawaguchi; H Ohnishi; T Sakamoto; K Shimizu; J Karasawa; H Furuya
Journal:  Skull Base Surg       Date:  1996

2.  Vecuronium requirement during liver transplantation under sevoflurane anesthesia.

Authors:  Kook-Hyun Lee; Soon-Ho Nam; Seung-Yeon Yoo; Chul-Woo Jung; Seng-Sim Bae; Jeong-Rim Lee
Journal:  J Anesth       Date:  2010-07-06       Impact factor: 2.078

3.  Sevoflurane and isoflurane impair edrophonium reversal of vecuronium-induced neuromuscular block.

Authors:  T Morita; D Kurosaki; H Tsukagoshi; T Sugaya; S Saito; H Sato; T Fujita
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

4.  Cumulation and reversal with prolonged infusions of atracurium and vecuronium.

Authors:  R J Martineau; B St-Jean; J B Kitts; M C Curran; P Lindsay; K A Hull; D R Miller
Journal:  Can J Anaesth       Date:  1992-09       Impact factor: 5.063

5.  Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.

Authors:  W S Beattie; D N Buckley; J B Forrest
Journal:  Can J Anaesth       Date:  1992-11       Impact factor: 5.063

6.  Sevoflurane enhances neuromuscular blockade by increasing the sensitivity of skeletal muscle to neuromuscular blockers.

Authors:  Ling Ye; Yunxia Zuo; Peng Zhang; Pingliang Yang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-25

7.  Effect of nitrous oxide on cisatracurium infusion demands: a randomized controlled trial.

Authors:  Hanna L Illman; Heikki Mj Antila; Klaus T Olkkola
Journal:  BMC Anesthesiol       Date:  2010-08-18       Impact factor: 2.217

8.  The neuromuscular effects of rocuronium under sevoflurane-remifentanil or propofol-remifentanil anesthesia: a randomized clinical comparative study in an Asian population.

Authors:  Sangseok Lee; Young Jin Ro; Won Uk Koh; Tomoki Nishiyama; Hong-Seuk Yang
Journal:  BMC Anesthesiol       Date:  2016-08-22       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.